Mass Spec
News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
The system, which will launch first in the EU and then the US and China, will be integrated into the company's existing Cobas Pro Integrated Solutions analyzer.
Launched in Europe in 2018 and the US in 2020, the fully automated mass spec-based analyzer failed to gain market traction, in large part due to a limited assay menu.
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
Japanese Consortium Launches Study to Evaluate Utility of Blood-Based Alzheimer's Markers
Shimadzu, Eisai, Oita University, and Usuki City Medical Association are studying the markers in 100 patients using Shimadzu's mass spec technology.
Thermo Fisher Q3 Revenues up 14 Percent
The company reported total revenues of $10.68 billion, up from $9.33 billion a year ago and beating the average Wall Street analyst estimate of $9.91 billion.